These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3234255)

  • 21. The broad field of forensic pharmacy.
    Anderson PD
    J Pharm Pract; 2012 Feb; 25(1):7-12. PubMed ID: 22251569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From pill-counting to patient care: pharmacists' standard of care in negligence law.
    Fleischer L
    Fordham Law Rev; 1999 Oct; 68(1):165-87. PubMed ID: 10848081
    [No Abstract]   [Full Text] [Related]  

  • 23. Medicinal products liability of the pharmacists: an overview of some emerging legal issues in Nigeria.
    Okeri HA; Okeri E
    World Health Popul; 2008 Mar; 10(1):5-17. PubMed ID: 18574339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State legal innovations to encourage naloxone dispensing.
    Davis C; Carr D
    J Am Pharm Assoc (2003); 2017; 57(2S):S180-S184. PubMed ID: 28073688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liability for errors in expanded pharmacy practice: issues for technicians and pharmacists.
    Cowley E; Baker KR
    J Am Pharm Assoc (Wash); 2000; 40(5 Suppl 1):S56-7. PubMed ID: 11029871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prosecution of Mélanie Hahnemann in 1847 at the court of Paris: illegal practise of pharmacy and medicine].
    Trépardoux F
    Rev Hist Pharm (Paris); 2002; 50(335):427-38. PubMed ID: 12515282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration-2017.
    Schneider PJ; Pedersen CA; Scheckelhoff DJ
    Am J Health Syst Pharm; 2018 Aug; 75(16):1203-1226. PubMed ID: 29903709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacy compounding of high-risk level products and patient safety.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuing education for the improvement of professional intervention in patient care.
    Moore RL
    Drug Intell Clin Pharm; 1980 Jun; 14(6):415-9. PubMed ID: 10247884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical guidelines: proliferation and medicolegal significance.
    Hurwitz B
    Qual Health Care; 1994 Mar; 3(1):37-44. PubMed ID: 10136259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASHP national survey of pharmacy practice in acute care settings: dispensing and administration--1999.
    Ringold DJ; Santell JP; Schneider PJ
    Am J Health Syst Pharm; 2000 Oct; 57(19):1759-75. PubMed ID: 11030028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Legal implications of diagnosis-related groups.
    Brooten KE
    Drug Intell Clin Pharm; 1986; 20(7-8):597-9. PubMed ID: 3091349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expert testimony: a perspective from the trenches.
    Hawkins TS
    J Am Coll Radiol; 2005 Feb; 2(2):126-30. PubMed ID: 17411781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing a clinical pharmacy technician at a United States Army military treatment facility.
    Evans JL; Gladd EM; Gonzalez AC; Tranam S; Larrabee JM; Lipphardt SE; Chen TT; Ronn MD; Spain J
    J Am Pharm Assoc (2003); 2016; 56(5):573-579.e1. PubMed ID: 27498312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A survey of state board of pharmacy members and continuing education providers' views on continuing education.
    Osterhaus JT; Gagnon JP
    Drug Intell Clin Pharm; 1985 Feb; 19(2):134-8. PubMed ID: 3971858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and conventional pharmacy services in Polish hospitals: a national survey.
    Pawłowska I; Pawłowski L; Kocić I; Krzyżaniak N
    Int J Clin Pharm; 2016 Apr; 38(2):271-9. PubMed ID: 26739130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacy legislation: public protector or professional hindrance?
    Langley CA
    Med Law Rev; 2014; 22(1):87-108. PubMed ID: 24327399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutional rights versus malpractice insurance settlements.
    Trentalance AE
    Physician Exec; 1994 Aug; 20(8):7-9. PubMed ID: 10139374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.